Pharmaceuticals company Hester Biosciences announced Q3FY25 results Divisional Product Sales: Rs 632.18 million, down 6% YoY from Rs 669.83 million Revenue from Operations: Rs 632.18 million, down 6% YoY from Rs 669.83 million Hester Nepal: Rs 8.09 million, up 2% YoY from Rs 7.91 million Hester Africa: Rs 8.05 million, up 11% YoY from Rs 7.26 million Gross Profit Margin: Rs 435.93 million, down 6% YoY from Rs 463.44 million EBITDA: Rs 138.45 million, up 12% YoY from Rs 123.53 million EBITDA %: 22%, up 4% YoY from 18% PAT: Rs 114.08 million, up 184% YoY from Rs 40.20 million PAT %: 18%, up 12% YoY from 6% EPS: Rs 13.41, up 184% YoY from 4.73 Result PDF